Arimidex anastrozole cancer data

Updated data from a previously reported 68-month follow-up of the ATAC trial

Read the full 129 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE